tirofiban has been researched along with Ischemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akdag, G; Arikan, FA; Aydin, HE; Cetiner, M; Eskut, N; Kabay, SC | 1 |
| Blankenship, JC; Demopoulos, L; DiBattiste, PM; Ellis, SG; Ghazzal, Z; Herrmann, HC; Martin, JL; Moliterno, DJ; Ross, MJ; Topol, EJ; White, J | 1 |
| White, CJ | 1 |
| Allie, AA; Allie, DE; Allie, SD; Chaisson, GA; Fail, PS; Hebert, CJ; Keller, VA; Khan, MA; Khan, MH; Lirtzman, MD; Mitran, EV; Stagg, SJ; Vitrella, DA; Walker, CM; Wyatt, CH | 1 |
| Allie, AA; Allie, DE; Allie, SE; Barker, EA; Chaisson, G; Fail, PS; Hebert, CJ; Keller, VA; Khan, MA; Khan, MH; Lirtzman, MD; McElderry, MW; Mitran, EV; Stagg, SJ; Vivekananthan, K; Walker, CM; Wyatt, CH | 1 |
1 trial(s) available for tirofiban and Ischemia
| Article | Year |
|---|---|
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Angiography; Double-Blind Method; Female; Humans; Immunoglobulin Fab Fragments; Ischemia; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Risk Assessment; Stents; Tirofiban; Tyrosine | 2003 |
4 other study(ies) available for tirofiban and Ischemia
| Article | Year |
|---|---|
Effect of Adiponectin on Acute Experimental Cerebral Ischemia/Reperfusion Injury.
Topics: Adiponectin; Animals; Brain Ischemia; Interleukin-1; Ischemia; Rats; Reperfusion Injury; Tirofiban; Tumor Necrosis Factor-alpha | 2023 |
Angiographic predictors of adverse outcomes in the modern interventional era.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Angiography; Humans; Immunoglobulin Fab Fragments; Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Risk Assessment; Stents; Tirofiban; Tyrosine | 2003 |
Continuous tenecteplase infusion combined with peri/postprocedural platelet glycoprotein IIb/IIIa inhibition in peripheral arterial thrombolysis: initial safety and feasibility experience.
Topics: Aged; Drug Therapy, Combination; Feasibility Studies; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Infusions, Intravenous; Ischemia; Leg; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Tenecteplase; Thrombolytic Therapy; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine | 2004 |
A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome.
Topics: Acute Disease; Aged; Angioplasty, Balloon; Anticoagulants; Feasibility Studies; Female; Follow-Up Studies; Hirudins; Humans; Ischemia; Leg; Male; Myocardial Ischemia; Peptide Fragments; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Retrospective Studies; Thrombin; Tirofiban; Treatment Outcome; Tyrosine | 2005 |